Sophont, a medical AI startup, announced Holon‑S1, a pan‑cancer model that predicts spatial gene and pathway activity from ordinary H&E pathology slides. The company says the model can show which genes are active and where, helping researchers find biomarkers and explore treatment options without expensive molecular tests. In a retrospective osteosarcoma case, Holon‑S1 reproduced insights that normally required months of lab work. The tool is currently offered for research use only.
Why it matters
Researchers can extract molecular‑level insights from existing slide archives, speeding biomarker discovery without new tissue samples.
